Diarylimidazolecarboxamides and diaryltriazolecarboxamides related to SR141716 were synthesized and tested for binding to the human CB1 receptor. Suitably substituted imidazoles are comparably potent to the clinical candidate, whereas the analogous triazoles are less so due to the absence of an additional substituent on the azole ring. (C) 2004 Elsevier Ltd. All rights reserved.
机构:
Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USA
Felder, CC
Glass, M
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USA
机构:
Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USA
Felder, CC
Glass, M
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USA